During the past decade, Hospital Pediátrico David Bernardino conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Pediátrico David Bernardino" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "Foundation for Paediatric Research, Finland" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Pediátrico David Bernardino" are "Bacterial Meningitis" (1 trials) and "Sickle Cell Disease" (1 trials). Many other conditions were trialed in "Hospital Pediátrico David Bernardino" in a lesser frequency.

Most popular intervention types in "Hospital Pediátrico David Bernardino" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bolus without paracetamol" (1 trials), "Hydroxyurea" (1 trials) and "Infusion with paracetamol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Pediátrico David Bernardino" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Pediátrico David Bernardino". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hospital Pediátrico David Bernardino, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Pediátrico David Bernardino, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".